Caption Management’s AbbVie ABBV Stock Holding History

Caption Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,700	Closed	-$7.25M	–	1599
2026 Q1	$7.33M	Buy	33,700 +17,600	+109%	+$3.9M	0.04%	417
2025 Q4	$3.68M	Buy	+16,100	New	+$3.67M	0.03%	607
2024 Q1	–	Sell	-29,700	Closed	-$5.12M	–	1127
2023 Q4	$4.6M	Buy	29,700 +26,000	+703%	+$3.79M	0.06%	366
2023 Q3	$552K	Buy	+3,700	New	+$543K	0.01%	913
2022 Q1	–	Sell	-75,500	Closed	-$11M	–	1405
2021 Q4	$10.2M	Buy	75,500 +57,500	+319%	+$6.79M	0.11%	228
2021 Q3	$1.94M	Buy	+18,000	New	+$2.06M	0.02%	770
2021 Q1	–	Sell	-44,300	Closed	-$4.75M	–	994
2020 Q4	$4.75M	Buy	+44,300	New	+$4.26M	0.11%	236
2019 Q2	–	Sell	-25,000	Closed	-$1.96M	–	641
2019 Q1	$2.02M	Buy	+25,000	New	+$2.05M	0.11%	236

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caption Management's ABBV Position: Q2 2026 in Review

Caption Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 33,700 shares — an estimated $7.25M sold.

Caption Management first reported a position in ABBV in Q1 2019 and held it in 8 quarters. The position peaked at $10.2M in Q4 2021. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Caption Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Caption Management sold 33,700 AbbVie shares in Q2 2026, an estimated $7.25M.
Caption Management first reported a position in AbbVie in Q1 2019 and held it in 8 quarters.
Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.